Skip to main content
. 2013 Feb 14;24(3):419–431. doi: 10.1681/ASN.2012070705

Figure 10.

Figure 10.

The development of anti-α3(IV)NC1 autoantibodies in DRB1*15:01 Tg or DRB1*01:01 Tg mice deficient in FcγRIIb (1501 Tg.FcγRIIb−/− and 0101 Tg.FcγRIIb−/−, respectively). (A) Sera from α3136–146 immunized and control mice (n=8 per group) are assayed for anti-murine α3(IV)NC1 antibodies, which are present to a similar titer in both strains of mice. However, only α3136–146 immunized 1501 Tg.FcγRIIb−/− mice developed IgG deposition in glomeruli (B), which when assessed by direct immunofluorescence is not present in α3136–146 immunized 0101 Tg.FcγRIIb−/− mice or nonimmunized mice (ctrl) of either strain. (C) IgG deposition is observed in glomeruli of all 8 α3136–146 immunized 1501 Tg.FcγRIIb−/− mice. Direct immunofluorescence reveals IgG staining of the glomerular basement membrane in a linear pattern with granular components in all mice (×1000). ***P<0.001.